NasdaqCM:SRTAHealthcare
Strata Critical Medical (SRTA) Stock Faces Clinical Progress And Lingering Losses
Strata Critical Medical stock barely budged on the earnings release, closing at US$5.58 and up less than 1%. The muted move sits awkwardly against a quarter built around one clear headline. Clinical services are now pulling more weight as the core earnings story while the broader group remains loss making.
Revenue reached US$72.5m for Q2 with adjusted earnings before interest, tax, depreciation and amortization margin at 10.9%. Management lifted full year revenue and adjusted earnings before...